DOT1L and cancer: CDK1 has been shown to phosphorylate and regulate distinct functions of several substrates, including disruptor of telomeric silencing 1-like (DOT1L), SRY-box transcription factor 2 (SOX2), and pyruvate dehydrogenase kinase 1 (PDK1), in various cancers [23–25].